Immune Dysregulation in Patients with Severe Acute Pancreatitis

被引:0
作者
YinFeng Shen
NaiQiang Cui
Bing Miao
ErPeng Zhao
机构
[1] Tianjin Medical University,National Medical Center of Biliopancreatic Diseases, Nankai Hospital, Nankai Clinical School
来源
Inflammation | 2011年 / 34卷
关键词
severe acute pancreatitis; immune dysregulation; cytokine; infection; organ dysfunction;
D O I
暂无
中图分类号
学科分类号
摘要
To investigate patients with severe acute pancreatitis (SAP) by dynamic levels of pro-/anti-inflammatory cytokines and endotoxin (ET) in plasma and the relationship between immunity and infection, organ dysfunction. Seventy-two patients with SAP were recruited. The ET, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin-10 (IL-10), and interleukin-4 (IL-4) were determined on admission and days 3, 7, and 14. For comparison, patients were analyzed through infection group versus non-infection group, multiple organ dysfunction syndrome (MODS) group versus non-MODS group. There were sixteen patients with secondary infection, twenty-two with MODS, and nine deaths. The infection group had higher levels of ET than the non-infection group on days 3 and 7. The dynamic cytokine levels of patients in the MODS group were unanimous with those outcomes in the infection group. The levels of cytokines in the infection group were different from the non-infection group, with more levels of TNF-α, IL-6 on days 3 and 7 and less on days 14, and more levels of IL-10, IL-4 on days7 and 14. The levels of TNF-α, IL-6 in the MODS group were different from the non-MODS group, with more levels on days 3 and 7, and less levels on days 14. Immune dysregulation may play an important role in infection and organ dysfunction for patients with SAP.
引用
收藏
页码:36 / 42
页数:6
相关论文
共 76 条
[1]  
Bumbasirevic V(2009)Severe acute pancreatitis: overall and early versus late mortality in intensive care units Pancreas 38 122-125
[2]  
Radenkovic D(2001)Towards a novel treatment strategy for acute pancreatitis. 1. Reappraisal of the evidence on aetiogenesis Digestion 63 69-91
[3]  
Jankovic Z(2004)Successful management of severe acute pancreatitis with multiple organ failure Pancreas 28 211-213
[4]  
Braganza JM(2003)Natural history of necrotizing pancreatitis Pancreatology 3 93-101
[5]  
Mizuguchi T(2000)Acute necrotizing pancreatitis: treatment strategy according to the status of infection Annals of Surgery 232 619-626
[6]  
Mukaiya M(2009)Microbiological findings in secondary infection of severe acute pancreatitis: a retrospective clinical study Pancreas 38 499-502
[7]  
Imaizumi H(2006)Evidence-based treatment of acute pancreatitis: a look at established paradigms Annals of Surgery 243 154-168
[8]  
Beger HG(2005)Polymorphism of the TNF-alpha, HSP70-2, and CD14 genes increases susceptibility to severe acute pancreatitis Pancreas 30 e46-e50
[9]  
Rau B(2009)Advances in researches on the immune dysregulation and therapy of severe acute pancreatitis Journal of Zhejiang University. Science. B 10 493-498
[10]  
Isenmann R(1993)A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992 Archives of Surgery 128 586-590